MassBio President & CEO Bob Coughlin was chosen to participate in an advisory committee created by House Speaker Robert A. DeLeo to to study managed care organizations (MCOs) and their impact on MassHealth costs. The committee is charged with reviewing the delivery of Medicaid health benefits by MCOs and analyzing the costs these organizations take on in their contracts with MassHealth. The group will also consider the costs of rare disease treatment medications and evaluate barriers to increasing adoption of alternative payment methods.

 

The 13-member group will begin meeting within 30 days and submit a report on its findings to the Speaker by October 1, 2015.

 

"On behalf of MassBio's 650+ member companies and organizations, we'd like to thank Speaker DeLeo for taking a thoughtful, proactive approach to understanding the managed care environment and how to best balance cost and benefits, including access to innovative medicines. We look forward to working with the other stakeholders on this effort," Coughlin said.